ADDF (investor - Others)
See something wrong or missing? Let us know
Offices:New York
ADDF - Alzheimer’s Drug Discovery Foundation - is an American charity using a venture philanthropy model for funding viable options to prevent or treat Alzheimer’s as well as pipeline of drugs in development for Alzheimer’s.
Average round investment:N/A USD
Average number per year:0.0
Distribution:
2024 (1)
Portfolio companies:
Glx Analytix
Glx Analytix
Mostly invests in:
Denmark (1)
AI (big data) (1)
Denmark (1)
AI (big data) (1)
1 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to ADDF
| Name | Criteria | |
|---|---|---|
![]() |
Mads Møller
89%
|
|
![]() |
Erik Mønster
89%
|
|
![]() |
DigitalDx Ventures
89%
|
|
![]() |
Labcorp
89%
|
|
![]() |
Hands-on Mikrofonden
86%
|
|
![]() |
Ribera Salud Group
86%
|
|
![]() |
Valentin Schmitt
86%
|
|
![]() |
Tim Juergens
86%
|
|
![]() |
Round One Ventures
86%
|
|
![]() |
Mauna Kea Advisory
86%
|
|






Belgium
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
United Kingdom